Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

11,011 total articles

Buy the AI-Memory Momentum: Tactical Long on Micron with a Defined Stop

Buy the AI-Memory Momentum: Tactical Long on Micron with a Defined Stop

Micron is flush with AI-driven demand: record data-center margins, a revenue surge, and strategic auto supply deals. The stock is trading below recent short-term moving averages but fundamentals (free cash flow $26.2B, ROE 50%) argue for a tactical long. This trade sets a clear entry, stop and target for a mid-term swing (45 trading days) while ack…

Corcept Therapeutics: Relacorilant Rejection Hurt Sentiment, But Fundamentals and Cash Flow Support a Risk-On Trade

Corcept Therapeutics: Relacorilant Rejection Hurt Sentiment, But Fundamentals and Cash Flow Support a Risk-On Trade

Corcept (CORT) cratered after a Complete Response Letter for relacorilant, but the company is cash-generative, debt-free and has rebuilt market value into 2026 highs. This trade idea buys the pullback/retest of recent strength with a defined stop and a 180-day time frame, accepting headline risk in exchange for 20%+ upside if catalysts materialize.

Medtronic: Undervalued With AI-Driven Surgical and Diabetes Tailwinds

Medtronic: Undervalued With AI-Driven Surgical and Diabetes Tailwinds

Medtronic is a cash-generating medical-device franchise trading at a modest multiple, supported by AI-enabled surgical growth, a broad product portfolio, and a defensible dividend. This trade idea outlines a long entry at ~$83 with a $100 target over 180 trading days and a $75 stop — a risk-managed way to own a high-quality medtech name while key c…

Newmont: Buy the Dip — Tactical Swing Into a High-Quality Gold Producer

Newmont: Buy the Dip — Tactical Swing Into a High-Quality Gold Producer

Newmont (NEM) pulled back sharply in June as gold prices slid and production guidance was trimmed. The market overreacted to a temporary hit to margins — Newmont's balance sheet strength, $9.24B in trailing free cash flow and an enlarged buyback provide a clear buy-the-dip setup. We recommend a tactical long with an explicit entry at $94.00, stop a…

Palantir’s Ontology Advantage: Buy the Pullback, Not the Hype

Palantir’s Ontology Advantage: Buy the Pullback, Not the Hype

Palantir (PLTR) has been swept up in a broad SaaS de-risking that knocked the stock nearly 40% off its 2025 peak. The fundamentals tell a different story: very high growth, strong profitability and cash generation, and an enterprise-grade ontology layer that’s hard to replicate. This trade idea outlines a long entry after the sell-off, with a measu…

A Contrarian Play on Whirlpool: Buying the Panic in an Appliance Cyclical

A Contrarian Play on Whirlpool: Buying the Panic in an Appliance Cyclical

Whirlpool is trading like the housing market will never recover: deeply discounted relative to recent history, weak margins, suspended dividend and legal probes. That said, the balance sheet and valuation suggest substantial upside if housing stabilizes and inventory normalization continues. This trade idea lays out a specific long entry, stop, tar…

Forte Biosciences: FB-102 Is Graduating Into a Platform Narrative — Trade the Re-rate, Defend With Stops

Forte Biosciences: FB-102 Is Graduating Into a Platform Narrative — Trade the Re-rate, Defend With Stops

Forte Biosciences is trading like a breakout biotech. Technical momentum and increasing short interest have produced a quick re-rate; the investment case now hinges on FB-102 being positioned as a platform that can drive multiple clinical programs. This trade idea recommends a tactical long with a clearly defined stop and target, while outlining th…

Buying Porsche ADRs Here: A Patient Long With Asymmetric Upside

Buying Porsche ADRs Here: A Patient Long With Asymmetric Upside

Porsche Automobil Holding SE's ADR (POAHY) is trading near its 52-week low on thin OTC liquidity but at compelling accounting multiples: market cap ~$9.35B, P/E ~3.2, and P/B ~0.21. With a modest dividend, a near-term payable date, depressed technicals (RSI ~33) and elevated short activity, the name presents an asymmetric risk/reward for patient lo…